Athira Pharma Report issue

For profit Phase 2
Founded: Seattle WA United States (2011)

Organization Overview

First Clinical Trial
2017
NCT03298672
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Athira Pharma | M3 | M3 Biotechnology, Inc.